10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 398,159 | 379,824 | 355,781 | 359,284 | 311,764 |
| Marketable Securities | N/A | 269 | 16,033 | 29,411 | 45,643 |
| Receivables | 83,525 | 91,178 | 91,305 | 114,832 | 103,847 |
| Inventories | 94,050 | 88,272 | 83,189 | 73,706 | 80,917 |
| TOTAL | $593,893 | $579,155 | $567,093 | $596,022 | $562,348 |
| Non-Current Assets | |||||
| PPE Net | 258,759 | 263,285 | 269,486 | 279,571 | 285,008 |
| Intangibles | 20,660 | 21,169 | 20,640 | 21,127 | 26,344 |
| Other Non-Current Assets | 64,482 | 66,059 | 65,694 | 68,423 | 74,840 |
| TOTAL | $343,901 | $350,513 | $355,820 | $369,121 | $386,192 |
| Total Assets | $937,794 | $929,668 | $922,913 | $965,143 | $948,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,210 | 21,248 | 20,216 | 15,738 | 18,836 |
| Accrued Expenses | 67,850 | 62,515 | 63,094 | 86,753 | 64,733 |
| TOTAL | $121,235 | $111,019 | $108,733 | $127,162 | $104,717 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,760 | 16,436 | 14,296 | 13,150 | 11,143 |
| Other Non-Current Liabilities | 81,406 | 83,233 | 85,559 | 88,124 | 98,607 |
| TOTAL | $93,755 | $94,591 | $95,346 | $96,938 | $98,607 |
| Total Liabilities | $214,990 | $205,610 | $204,079 | $224,100 | $203,324 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,054 | 120,491 | 119,708 | 119,167 | 118,209 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,418,019 | -1,382,266 | -1,344,369 | -1,284,420 | -1,235,468 |
| Other shareholders' equity | 32 | -430 | -456 | -429 | -677 |
| TOTAL | $722,804 | $724,058 | $718,834 | $741,043 | $745,216 |
| Total Liabilities And Equity | $937,794 | $929,668 | $922,913 | $965,143 | $948,540 |